黑料正能量Health Meeting Overview
The 黑料正能量Health Meeting is a dynamic, inclusive scientific ecosystem that brings together professionals from across the clinical, public health, biomedical and translational research spectrum to tackle urgent challenges at the intersection of microbial science and human and animal health. By combining the Antimicrobial Agents and Resistance (AAR), Clinical and Public Health Microbiology (CPHM) and Clinical Infections and Vaccines (CIV) communities together, this new meeting fosters a holistic, multi-disciplinary approach to understanding infectious diseases, innovating diagnostics and treatment and strengthening global health resilience.
With a commitment to advancing microbial science for societal benefit with a focus on diagnostics, prevention, therapeutics, surveillance and microbiome, the 黑料正能量Health Meeting is designed for a cross-cutting dialogue across academic, clinical, public health and industry sectors.
Key Focus Areas
- Diagnostics and Laboratory Systems: diagnostic microbiology and clinical lab operations that improve the speed, accuracy and equity of infectious disease detection, including molecular diagnostics, automation, AI, stewardship and decentralized testing for clinical and public health use.
- Vaccines, Immunology and Prevention: novel vaccine technologies, immunological profiling and prevention strategies for infectious diseases in humans and animals, including translational immunology, innovative platforms (e.g., mRNA, vector-based), population-level prevention and immune-based diagnostics.
- Antimicrobials and Therapeutics: discovery, development and application of antimicrobial and non-traditional therapies, including mechanisms of action, resistance, pharmacodynamics and emerging treatments (e.g. phages and peptides). Other innovative solutions for antimicrobial resistance, tolerance, and toxicity.
- Clinical Infectious Disease and Management: diagnosis, treatment and clinical management of infectious diseases across patient populations and health care settings, including adult and pediatric care, infections in immunocompromised patients, global disease patterns, hospital acquired infections with an emphasis on evidence base practice to improve patient outcomes.
- Public Health, Surveillance and Systems: microbial surveillance systems to generate actionable insights to prevent, detect and respond to infectious disease threats, including genomic and environmental surveillance, AMR tracking and real-time outbreak response across human, animal and environmental health.
- Microbiomes and Ecosystems Health: exploration of microbiomes across humans, animals, plants and the environment, including functions, interactions and therapeutic potential. Integrating systems of biology and engineered interventions to advance applications in health, agriculture and climate resilience.
Submit a session proposal to be a part of the inaugural 黑料正能量Health Meeting taking place June 4-8, 2026 in Washington, D.C. Explore the frontiers of clinical and public health microbiology—from innovative diagnostics, therapeutics and vaccines to new approaches in prevention, surveillance and control.